SOURCE: Zynex, Inc.

Zynex,  Inc.

July 27, 2011 09:01 ET

Zynex Schedules Second Quarter 2011 Earnings Release and Webcast

LONE TREE, CO--(Marketwire - Jul 27, 2011) - Zynex, Inc. (OTCBB: ZYXI), a provider of non-invasive medical devices for electrotherapy and stroke rehabilitation, neurological diagnosis and cardiac monitoring, announced today that it will host an investor webcast, Wednesday, August 3, 2011 at 9:00 a.m. Mountain Time - 11:00 a.m. Eastern Time to discuss the Company's second quarter results.

The Company expects to release second quarter 2011 financial results on Wednesday, August 3, 2011, prior to the market open.

Webcast Details: Wednesday, August 3, 2011 at 9:00 a.m. MT - 11:00 a.m. ET
To register and participate in the webcast, interested parties should click on the following link approximately 10-15 minutes prior to the webcast:
http://www.visualwebcaster.com/event.asp?id=81276

Please note: questions can only be submitted via the webcast user interface. Parties without access to the internet may join the presentation in listen only mode by dialing the toll free number provided below.

Phone Access Details
Participant Toll Free Dial-in Number: 888-208-1814
Participant Phone Access Passcode: 3744529

About Zynex
Zynex, Inc. (founded in 1996), operates under three primary business segments; Zynex Medical, Zynex NeuroDiagnostics and Zynex Monitoring Solutions. Zynex Medical engineers, manufactures, markets and sells its own design of electrotherapy medical devices for standard digital electrotherapy, used for pain relief, pain management and stroke and spinal cord injury rehabilitation. Zynex Medical's product lines are fully developed, FDA-cleared, commercially sold, and have been developed to uphold the Company's mission of improving the quality of life for patients suffering from impaired mobility due to stroke, spinal cord injury, or debilitating and chronic pain. Zynex NeuroDiagnostics, currently in the development stage, has been established to market EMG, EEG, sleep pattern, auditory and nerve conductivity neurological diagnosis devices through product development or acquisitions. Zynex Monitoring Solutions, currently in the development stage, has been established to develop and market medical devices for non-invasive cardiac monitoring.

For additional information, please visit: http://www.ir-site.com/zynex/default.asp.

Safe Harbor Statement
Certain statements in this release are "forward-looking" and as such are subject to numerous risks and uncertainties. Actual results may vary significantly from the results expressed or implied in such statements. Factors that could cause actual results to materially differ from forward-looking statements include, but are not limited to, the need to obtain additional capital in order to grow our business, our ability to engage additional sales representatives, the success of such additional sales representatives, the need to obtain FDA clearance and CE marking of new products, the acceptance of new products as well as existing products by doctors and hospitals, larger competitors with greater financial resources, the need to keep pace with technological changes, our dependence on the reimbursement from insurance companies for products sold or rented to our customers, acceptance of our products by health insurance providers, our dependence on third party manufacturers to produce our goods on time and to our specifications, implementation of our sales strategy including a strong direct sales force, the uncertain outcome of pending material litigation and other risks described in our filings with the Securities and Exchange Commission including the "Risk Factors" section of our Annual Report on Form 10-K for the year ended December 31, 2010.

Contact Information

  • Contact:
    Zynex, Inc.
    Anthony Scalese
    CFO
    303-703-4906